is igf-1 lr3 legal LONG® R³ IGF-I IGF-1LR3
Description
Kjrgaard, J
See the full protocol in the peptide dosage chart
Analysis of PB1 (IAV) transcripts was performed with SYBR Green-based qPCR using the following primers: forward: 5-ACACAAGGCCGACAGACCTA-3 and reverse: 5-ATGCTGTTGCAGCAGGTTGG-3 and Actb (QIAGEN
Similarly, some other ongoing clinical studies on mRNA-LNP drug candidates for other infectious diseases are mRNA-1893 (Phase 2, NCT04917861) against Zika virus, mRNA-1215 (Phase 1, NCT05398796) against Nipah virus, H1ssF-3928 (Phase 1, NCT05755620) against influenza, mRNA-1189 (Phase 1, NCT05164094) against Epstein Virus, among others
